Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study.
Elisabeth Reinhardt MathiesenNorsiah AliAmra C AlibegovicEleni AnastasiouKatarzyna CyprykHarold de ValkJorge DoresFidelma DunneMari-Anne GallSantiago Duran GarciaHélène P HanaireLise Lotte N HusemoenMarina IvaniševićHans-Peter KempeDavid R McCancePeter DammPublished in: Diabetes care (2021)
Insulin detemir was associated with a similar risk to other basal insulins of major congenital malformations, perinatal or neonatal death, hypoglycemia, preeclampsia, and stillbirth.